Form 4 for CBT CABOT CORP
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-11 · accession 0001209191-22-056977 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-15 | 2022-11-11 | CBT | Keohane Sean D | Pres, CEO, Dir | A - Grant | $0.00 | +21.9K | 275.7K | +9% | $0 |
| D | 2022-11-15 | 2022-11-11 | CBT | Keohane Sean D | Pres, CEO, Dir | A - Grant | $0.00 | +71.9K | 71.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | A | A | 21,939 | $0.00 | 275,737 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2022-11-11 | A | A | 71,917 | $0.00 | 71,917 | D | $73.84 · — to 2032-11-10 | 71,917 Common Stock | (F1) The option vests over a three year period as follows: 30% on November 11, 2023, 30% on November 11, 2024 and 40% on November 11, 2025. |